the aid library

LIST OPTIONS

Filter

341

View PDF (1937)

Solomon Islands Essential Medical Supplies List 2017

Sandy Greenwood, Timmy Manea, Willie Horoto et al. National Pharmacy Services Division, Ministry of Health & Medical Services (2017) CC

Solomon Islands pharmacy staff have developed an essential medicines supplies list. It was a collaborative effort involving a lot of staff taking the pictures and putting it all together. The list was launched as an initiative to improve the availability of medical stock within the country

Download (469)

View PDF (229)

National guideline for management of Non Communicable Diseases(NCDs)

Rwanda Biomedical Center Ministry of Health Rwanda (2016) CC

Non-Communicable Diseases (NCDs) are a worldwide epidemic. Particularly, the most common diseases - Cardiovascular diseases, Chronic Obstructive Pulmonary Diseases (COPD), Chronic Kidney Diseases, Cancer, Diabetes, injuries and disabilities, EMT, oral, eye g... more

Download (262)

View PDF (209)

Hepatitis Virales - Guía para el diagnóstico y tratamiento de la infección por el virus de las hepatitis B y C

Coordinación Nacional de Hepatitis Virales Ministerio de Salud Argentina (2021) C2

Los objetivos de las guías son brindar directrices para optimizar el cuidado de la mayoría de los pacientes afectados por los VHB y VHC. Sin embargo, no reemplazan el criterio médico en la valoración y abordaje del paciente individual. En situaciones especiales, el mejor enfoque en el diagnóst... more

Download (1510)

View PDF (1618)

Assessment tool for the quality of hospital care for mothers and newborn babies
recommended

World Health Organization (2009) C_WHO

Download (1385)

View PDF (595)

mhGAP Intervention Guide Mental Health Gap Action Programme Version 2.0 for mental, neurological and substance use disorders in non-specialized health settings
recommended

Tarun Dua, Nicolas Clark, Neerja Chowdhary et al. World Health Organisation (WHO) (2016) C_WHO

The key updates include: content update in various sections based on new evidence; design changes for enhanced usability; a streamlined and simplified clinical assessment that includes an algorithm for follow-up; inclusion of two new modules - Essential Care and Practice that includes general guid... more

Download (177)

View PDF (158)

Guidance for clinical case management of thrombosis with thrombocytopenia syndrome (‎TTS)‎ following vaccination to prevent coronavirus disease (‎COVID-19)‎: interim guidance, 19 July 2021

World Health Organization WHO (2021) C_WHO

Download (542)

View PDF (733)

National Guidelines for the Facility-based Management of Children with Severe Acute Malnutrition in Bangladesh

Government of People’s Republic of Bangladesh, Ministry of Health and Family Welfare, Directorate General of Health Services ... (2017) C1

Level of stunting among Bangladeshi children <5years declined from 51% in 2004 to 36% and underweight from 41% in 2007 to 33% (BDHS 2014). But the decrease in wasting rate is not as expected, which is only from 17% to 14.3 % over last decade. Approximately 3.1 % (BDHS 2014) of under-5 children suffe... more

Download (1155)

View PDF (855)

List of Medicines for Community Pharmacy, Ethiopia (LMCP)

Food, Medicine and Health care Administration and Control Authority of Ethiopia (FMHACA) (2012) C1

Fourth Edition

Download (1157)

View PDF (1153)

List of Medicines for Ethiopia

Food, Medicine and Healthcare Administration and Control Authority of Ethiopia (2010) C1

6th edition

Download (260)

View PDF (329)

Guidelines forPrevention and Management of Stroke
recommended

National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases & Stroke (NPCDCS), India (2019) C2

Download (138)

View PDF (162)

Guía de Práctica Clínica: Para el abordaje sindrómico del diagnóstico y tratamiento de los pacientes con infecciones de transmisión sexual y otras infecciones del tracto genital

Ministerio de Salud y Protección Social Colombia Asociación Colombiana de Infectiologiá ACIN (2013) C1

Download (341)

View PDF (358)

Essential List for screening, monitoring and treatment for diabetic retinopathy

International Agency for Prevention of Blindness IAPB (2018) C1

3rd edition April 2018 - draft version This Essential List for Diabetic Retinopathy contains recommendations for a range of essential itemsrequired at community / primary level (for screening); at secondary and tertiary levels (for treatment and follow up). It also contains recommendations for i... more

Download (491)

View PDF (1108)

The Wise List 2015

Stockholm Drug and Therapeutics Committee (2015) C_WHO

with recommended essential medicines for common diseases in patients in Stockholm County Council (Healthcare Region), Sweden

Download (331)

View PDF (442)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (129)

View PDF (175)

Tracking official development assistance for reproductive health in conflict-affected countries: 2002—2011

Patel P.; Dahab M.; Tanabe M. et al. BJOG An International Journal of Obstetics and Gynaecology (2016) CC

To provide information on trends on official development assistance (ODA) disbursement patterns for reproductive health activities in 18 conflict-affected countries

External Link

Lista de medicamentos esenciales

Ministerio de salud pública y bienestar social, Paraguay (2009) C_WHO

Download (2274)

View PDF (2551)

Treatment of Mycobacterium Ulcerans Disease (Buruli Ulcer)
recommended

World Health Organization WHO WHO (2012) C_WHO

Guidance for health workers

Download (2696)

View PDF (4230)

National List of Essential Medicines for Adults Rwanda 6th edition

Republic of Rwanda, Ministry of Health (2015) C1

The essential medicines are those that meet the priority needs of the healthcare of the population. While reviewing the 5th edition of the essential Medicines, special attention focused on the health sector policy. Indeed, medicines play an important role in protecting, maintaining and restoring th... more

Download (217)

View PDF (236)

Manuel de l’Utilisation Optimale du Sang

Optimal Blood Use Project (2010) CC

La sécurité du traitement hospitalier et la réalité des soins sont des préoccupations majeures dans les systèmes de santé. La transfusion sanguine a fait l’objet de procédures juridiques et d’études au Canada, en Angleterre, en France, en Irlande et dans d’autres pays. Il conviendr... more

Download (3460)

View PDF (3238)

Standard Treatment Guidelines. Nigeria

Federal Ministry of Health Nigeria , World Health Organisation (WHO) (2008) C_WHO

Assessment tool for the quality of hospital care for mothers and newborn babies recommended

mhGAP Intervention Guide Mental Health Gap Action Programme Version 2.0 for mental, neurological and substance use disorders in non-specialized health settings recommended

Guidelines forPrevention and Management of Stroke recommended

Treatment of Mycobacterium Ulcerans Disease (Buruli Ulcer) recommended

Assessment tool for the quality of hospital care for mothers and newborn babies
recommended

mhGAP Intervention Guide Mental Health Gap Action Programme Version 2.0 for mental, neurological and substance use disorders in non-specialized health settings
recommended

Guidelines forPrevention and Management of Stroke
recommended

Treatment of Mycobacterium Ulcerans Disease (Buruli Ulcer)
recommended